Submitted by Anonymous (not verified) on 4 August 2023 - 11:41
Human medicines European public assessment report (EPAR): Arikayce liposomal, amikacin, Respiratory Tract Infections, Date of authorisation: 27/10/2020, Revision: 2, Status: Authorised
Source: